Azadeh is an Australian qualified solicitor and joined EIP from one of the largest specialist IP firms in Australia. She has advised both innovator and generic multi-national pharmaceutical companies throughout all stages of contentious patent proceedings, with experience in small-molecules, biologics and biosimilars. She notably represented ICOS (Eli Lilly) in a high profile case in the Federal Court of Australia.
Azadeh has a BSc in Biomedical Science and a Juris Doctor from Murdoch University, and a Graduate Diploma of Legal Practice from the Australian College of Law.
Experience
- Apotex Pty Ltd v ICOS Corporation (No 3) [2018] FCA 1204
- Apotex Pty Ltd v ICOS Corporation [2017] FCA 466
Published articles
- June 2022
Newsflash, Patents Court affirms power to grant injunctions for pre-grant patents, but Novartis loses on interim relief and refused permission to appeal by Birss LJ for Gilenya® (link)
Specialities
- Pharmaceuticals
Education and qualifications
-
2015 — 2016
Graduate Diploma of Legal Practice , College of Law (Australia) -
2011 — 2014
Juris Doctor, Murdoch University -
2007 — 2010
BSc Biomedical Science, Murdoch University
Career history
- 2020 — present
Associate, EIP - 2016 — 2019
Lawyer, Wrays - 2014 — 2016
Analyst, Deloitte
Languages spoken
- Farsi (fluent)